Holders — by stockHoldings — by fund
Deep Track Capital, LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001856083
$6.14B
disclosed book value
73
positions
8.2%
largest position share
Positions, as of 2026-09-30
top 74 of 73 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | GHGUARDANT HEALTH INC | 2.8M | $500.4M | 8.2% |
| 2 | BMRNBIOMARIN PHARMACEUTICAL INC | 6.4M | $382.5M | 6.2% |
| 3 | IMVTIMMUNOVANT INC | 9.2M | $309.5M | 5% |
| 4 | TARSTARSUS PHARMACEUTICALS INC | 3.8M | $299.3M | 4.9% |
| 5 | MANEVERADERMICS INC | 1.9M | $230.3M | 3.8% |
| 6 | VERAVERA THERAPEUTICS INC | 7.0M | $226.0M | 3.7% |
| 7 | PCVXVAXCYTE INC | 3.5M | $199.9M | 3.3% |
| 8 | ALKSALKERMES PLC | 4.5M | $182.3M | 3% |
| 9 | OCULOCULAR THERAPEUTIX INC | 21.9M | $168.3M | 2.7% |
| 10 | UTHRUNITED THERAPEUTICS CORP DEL | 300,040 | $162.6M | 2.6% |
| 11 | GPCRSTRUCTURE THERAPEUTICS INC | 5.0M | $156.3M | 2.5% |
| 12 | GRALGRAIL INC | 1.1M | $154.7M | 2.5% |
| 13 | INSMINSMED INC | 1.4M | $154.1M | 2.5% |
| 14 | CMPSCOMPASS PATHWAYS PLC | 12.2M | $151.3M | 2.5% |
| 15 | GMABGENMAB A/S | 4.2M | $149.2M | 2.4% |
| 16 | AXSMAXSOME THERAPEUTICS INC. | 800,000 | $147.5M | 2.4% |
| 17 | NRIXNURIX THERAPEUTICS INC | 6.0M | $142.3M | 2.3% |
| 18 | LBRXLB PHARMACEUTICALS INC | 3.4M | $128.7M | 2.1% |
| 19 | TNGXTANGO THERAPEUTICS INC | 4.5M | $112.3M | 1.8% |
| 20 | MAZEMAZE THERAPEUTICS INC | 4.1M | $111.0M | 1.8% |
| 21 | COAGHEMAB THERAPEUTICS HLDGS INC | 3.6M | $110.6M | 1.8% |
| 22 | GMABGENMAB A/SCALL | 2.8M | $98.5M | 1.6% |
| 23 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 8.1M | $94.8M | 1.5% |
| 24 | ORKAORUKA THERAPEUTICS INC | 1.1M | $89.1M | 1.5% |
| 25 | WGSGENEDX HOLDINGS CORP | 1.2M | $86.8M | 1.4% |
| 26 | TEMTEMPUS AI INCCALL | 1.0M | $81.9M | 1.3% |
| 27 | COGTCOGENT BIOSCIENCES INC | 2.5M | $80.0M | 1.3% |
| 28 | GHRSGH RESEARCH PLC | 3.3M | $78.3M | 1.3% |
| 29 | BCAXBICARA THERAPEUTICS INC | 4.1M | $76.3M | 1.2% |
| 30 | LTGOLATIGO BIOTHERAPEUTICS INC | 4.4M | $73.6M | 1.2% |
| 31 | CLDXCELLDEX THERAPEUTICS INC NEW | 2.1M | $68.9M | 1.1% |
| 32 | BBIOBRIDGEBIO PHARMA INC | 885,882 | $58.3M | 0.9% |
| 33 | AVTXAVALO THERAPEUTICS INC | 3.6M | $55.3M | 0.9% |
| 34 | ALMSALUMIS INC | 7.5M | $55.2M | 0.9% |
| 35 | ALTALTIMMUNE INC | 19.3M | $55.1M | 0.9% |
| 36 | ATTOATTOVIA THERAPEUTICS INC | 3.2M | $55.0M | 0.9% |
| 37 | BLLNBILLIONTOONE INC | 500,000 | $53.2M | 0.9% |
| 38 | ACRSACLARIS THERAPEUTICS INC | 9.3M | $49.2M | 0.8% |
| 39 | CRMDCORMEDIX INC | 6.3M | $48.3M | 0.8% |
| 40 | EWTXEDGEWISE THERAPEUTICS INC | 1.1M | $46.6M | 0.8% |
| 41 | VSTMVERASTEM INC | 5.7M | $46.2M | 0.8% |
| 42 | DFTXDEFINIUM THERAPEUTICS INC | 1.0M | $38.1M | 0.6% |
| 43 | GENBGENERATE BIOMEDICINES INC | 2.5M | $37.7M | 0.6% |
| 44 | MBXMBX BIOSCIENCES INC | 640,000 | $37.5M | 0.6% |
| 45 | ANIPANI PHARMACEUTICALS INC | 500,000 | $36.3M | 0.6% |
| 46 | VRDNVIRIDIAN THERAPEUTICS INC | 1.7M | $35.2M | 0.6% |
| 47 | HROWHARROW INC | 1.1M | $32.9M | 0.5% |
| 48 | OBXOBSIDIAN THERAPEUTICS INC | 2.1M | $29.1M | 0.5% |
| 49 | CRVSCORVUS PHARMACEUTICALS INC | 2.5M | $28.7M | 0.5% |
| 50 | NBIXNEUROCRINE BIOSCIENCES INC | 200,000 | $28.4M | 0.5% |
| 51 | SLDBSOLID BIOSCIENCES INC | 3.6M | $25.8M | 0.4% |
| 52 | STTKSHATTUCK LABS INC | 3.7M | $25.3M | 0.4% |
| 53 | BEAMBEAM THERAPEUTICS INC | 1.0M | $24.4M | 0.4% |
| 54 | MNKDMANNKIND CORP | 5.0M | $19.6M | 0.3% |
| 55 | XENEXENON PHARMACEUTICALS INC | 500,000 | $18.6M | 0.3% |
| 56 | OLMAOLEMA PHARMACEUTICALS INC | 2.1M | $18.2M | 0.3% |
| 57 | NKTRNEKTAR THERAPEUTICS | 300,000 | $18.2M | 0.3% |
| 58 | DSGNDESIGN THERAPEUTICS INC | 1.3M | $16.6M | 0.3% |
| 59 | IPSCCENTURY THERAPEUTICS INC | 9.5M | $16.2M | 0.3% |
| 60 | DYNDYNE THERAPEUTICS INCCALL | 1.0M | $16.1M | 0.3% |
| 61 | XNCRXENCOR INC | 540,000 | $13.5M | 0.2% |
| 62 | MPLTMAPLIGHT THERAPEUTICS INC | 1.3M | $13.4M | 0.2% |
| 63 | ENTAENANTA PHARMACEUTICALS INC | 1.0M | $13.2M | 0.2% |
| 64 | XFORX4 PHARMACEUTICALS INC | 4.5M | $13.1M | 0.2% |
| 65 | KARDKARDIGAN INC | 600,000 | $8.8M | 0.1% |
| 66 | PMNPROMIS NEUROSCIENCES INC | 740,117 | $8.0M | 0.1% |
| 67 | ENTXENTERA BIO LTD | 2.5M | $7.1M | 0.1% |
| 68 | RXSTRXSIGHT INC | 1.2M | $6.0M | 0.1% |
| 69 | RNAQURAINIER ACQUISITION CORP | 500,000 | $5.1M | 0.1% |
| 70 | JTTTJATT III ACQUISITION CORP | 450,000 | $5.0M | 0.1% |
| 71 | RACDRESEARCH ALLIANCE CORP IV | 400,000 | $4.6M | 0.1% |
| 72 | TCGXTCGX ACQUISITION CORP | 300,000 | $3.8M | 0.1% |
| 73 | ALGSALIGOS THERAPEUTICS INC | 444,110 | $2.5M | 0% |
| 74 | CNTXCONTEXT THERAPEUTICS INC | 7.4M | $2.2M | 0% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.